LCM
IMMU

Laurion Capital Management’s Immunomedics Inc IMMU Stock Holding History

Laurion Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-49,009
Closed -$1.74M – 1264
2020
Q2 		$1.74M Buy
+49,009
New +$1.43M 0.02% 337
2020
Q1 		– Sell
-208,839
Closed -$4.42M – 1216
2019
Q4 		$4.42M Buy
+208,839
New +$3.68M 0.03% 324
2017
Q4 		– Sell
-44,115
Closed -$617K – 1973
2017
Q3 		$617K Buy
+44,115
New +$440K ﹤0.01% 1102

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Laurion Capital Management's IMMU Position: Q3 2020 in Review

Laurion Capital Management sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 49,009 shares — an estimated $1.74M sold.

Laurion Capital Management first reported a position in IMMU in Q3 2017 and held it in 3 quarters. The position peaked at $4.42M in Q4 2019. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Laurion Capital Management reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Laurion Capital Management sold 49,009 Immunomedics Inc shares in Q3 2020, an estimated $1.74M.
  • Laurion Capital Management first reported a position in Immunomedics Inc in Q3 2017 and held it in 3 quarters.
  • Laurion Capital Management's Immunomedics Inc position peaked at $4.42M in Q4 2019.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Laurion Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.